Showing results (111-120 of 269) with videos related to

Sort By:
Pageof 27
Antimicrobial Agents and Chemotherapy|May 20, 2024
Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatmentNavarat Panjasawatwong, Anchalee Avihingsanon, Caroline Menétrey, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2025
Pharmacokinetics and tolerability of one-month daily rifapentine for latent tuberculosis treatment in haemodialysis patientsThornthun Ueaphongsukkit, Suwasin Udomkarnjananun, Jakapat Vanichanan, et al.
AIDS Care|December 16, 2014
Low uptake of HIV testing and no HIV positivity in stable serodiscordant heterosexual partners of long-term treated HIV-infected ThaisNadia Kancheva Landolt, Nittaya Phanuphak, Chuleeporn Khongpetch, et al.
The Lancet Regional Health. Southeast Asia|May 7, 2025
Cause of death in people living with HIV who initiated antiretroviral therapy after enrolling to the Thai National AIDS Program from 2008 to 2021Cheewanan Lertpiriyasuwat, Stephen J Kerr, Sairat Noknoy, et al.
HIV Medicine|April 24, 2026
Prognostic value of ankle-brachial index and cardio-ankle vascular index for mortality and cardiovascular events in older people with HIV on long-term ARTPorntep Amornritvanich, Sarawut Siwamogsatham, Pairoj Chattranukulchai, et al.
Tuberculosis (Edinburgh, Scotland)|November 30, 2020
Performance of a simple flow cytometric assay in diagnosing active tuberculosisSasiwimol Ubolyam, Thatri Iampornsin, Jiratchaya Sophonphan, et al.
AIDS (London, England)|November 10, 2009
Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndromeWeerawat Manosuthi, Hong Van Tieu, Wiroj Mankatitham, et al.
Hepatology (Baltimore, Md.)|December 31, 2008
Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapySharon R Lewin, Ruy M Ribeiro, Anchalee Avihingsanon, et al.
Antiviral Therapy|August 22, 2012
Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patientsReshmie A Ramautarsing, Jasper van der Lugt, Meena Gorowara, et al.
The Journal of Infectious Diseases|October 10, 2020
Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell ModulationCarolyn A Luscombe, Anchalee Avihingsanon, Khuanchai Supparatpinyo, et al.
Pageof 27